Cardiac shock wave therapy (CSWT) is a noninvasive new therapeutic option in the treatment of chronic refractory angina pectoris. Many domestic and international researches have revealed that CSWT contributes to revascularization by stimulating angiogenesis. We were aimed to evaluate the safety and efficiency of CSWT in the treatment of refractory angina.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
200
Ultrasound guided cardiac shock wave therapy (CSWT) is a new treatment method offering an alternative to revascularization by stimulating angiogenesis. Subsequent clinical trials showed that CSWT could reduce symptoms of myocardial ischemia and improve cardiac function in patients with severe coronary artery disease.
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China
Canadian Cardiovascular Society (CCS) grading of angina
questionnaire of Canadian Cardiovascular Society grading of angina concerning exercise tolerance
Time frame: 6 months
Seattle angina questions (SAQ)
questionnaire of Seattle angina questions to evaluate the effect of coronary artery disease on patients' life quality
Time frame: 6 months
6-min walk test
All participants will receive a 6 minutes' walk test to evaluate their effect of treatment of cardiac shock wave therapy
Time frame: 6 months
Nitrate consumption
All participants will receive a questionnaire of the amount of nitrate they need before and after treatment of cardiac shock wave therapy
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.